Effect of a new multifactorial antihypertensive on heart morphology and function in mild to moderate essential arterial hypertension

Eur Heart J. 1992 Jun:13 Suppl A:45-8. doi: 10.1093/eurheartj/13.suppl_a.45.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adrenergic alpha-Antagonists / pharmacology
  • Adrenergic alpha-Antagonists / therapeutic use*
  • Adult
  • Antihypertensive Agents / pharmacology
  • Antihypertensive Agents / therapeutic use*
  • Cardiomegaly / diagnostic imaging
  • Cardiomegaly / drug therapy*
  • Cardiomegaly / etiology
  • Double-Blind Method
  • Echocardiography
  • Female
  • Heart Ventricles / diagnostic imaging
  • Heart Ventricles / drug effects
  • Humans
  • Hypertension / complications
  • Hypertension / diagnostic imaging
  • Hypertension / drug therapy*
  • Male
  • Middle Aged
  • Piperazines / pharmacology
  • Piperazines / therapeutic use*
  • Ventricular Function / drug effects

Substances

  • Adrenergic alpha-Antagonists
  • Antihypertensive Agents
  • Piperazines
  • urapidil